Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED)
Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED)
Patients receiving a patient assistance program during therapy for Hepatitis C will be
 enrolled into this study. All patients will receive PegIntron pen and Rebetol according to
 label and the patient assistance program. This study will be compared to similar studies from
 other clinics using various patient support programs for the purpose of designing future
 comparative phase IV studies.
Inclusion Criteria:

 -  Adult patients with hepatitis C

 Exclusion Criteria:

 -  According to the products' labeling (refer to Warnings, contraindications, and safety
 sections).